National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 11) (PB 104 of 2016) (Cth)

PB 104 of 2016

National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 11)

National Health Act 1953

I, LOUISE CLARKE, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated      29^th  November 2016

LOUISE CLARKE

Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 11).

   (2)   This Determination may also be cited as PB 104 of 2016.

2. Commencement

   This Determination commences on 1 December 2016.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Arginine with carbohydrate

Omit

Aripiprazole

[2]     Schedule 1, after item dealing with Biperiden

Omit

Bivalirudin

[3]     Schedule 1, after item dealing with Entacapone

Omit

Entecavir

[4]     Schedule 1, after item dealing with Everolimus

Insert

Evolocumab

[5]     Schedule 1, after item dealing with High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate

Omit

Homatropine

[6]     Schedule 1, after item dealing with Isoniazid

Omit

Itraconazole

[7]     Schedule 1, after item dealing with Lenograstim

Insert

Lenvatinib

[8]     Schedule 1, after item dealing with Obinutuzumab

Insert

Ocriplasmin

[9]     Schedule 1, after item dealing with Rivaroxaban

Omit

Rivastigmine

[10]   Schedule 2, after item dealing with Apomorphine

Insert

Aripiprazole

[11]   Schedule 2, after item dealing with Bisoprolol

Insert

Bivalirudin

[12]   Schedule 2, after item dealing with Enalapril with hydrochlorothiazide

Insert

Entecavir

[13]   Schedule 2, after item dealing with Isotretinoin

Insert

Itraconazole

[14]   Schedule 2, after item dealing with Olmesartan

Insert

Olmesartan with amlodipine

Olmesartan with hydrochlorothiazide

[15]   Schedule 2, after item dealing with Risperidone

Insert

Rivastigmine